|
|
alt.support.food-allergies |
In article > Does the study distinguish if OCTN2 (carnitine transporter) reduction
<edd2ecbf-aa30-45c8-84fe-d0af18522...@p20g2000vbl.googlegroups.com>,
jay <jaym1...@hotmail.com> wrote: Given that supplemental carnitine in liposomes has alleviated TNBS
> > OCTN2 is upregulated by intermittent fasting, exercise, PPARalpha
> > agonists and, I think, testosterone. It's vital for carnitine uptake
> > (which is antiinflammatory in the gut) and butyrate metabolism (crucial
> > for HDAC inhibition).
> >
> > Changes in mRNA expression levels of solute carrier transporters in
> > inflammatory bowel disease patients...
> causes IBD or that OCTN2 is simply reduced during inflammation?
colitis in mice when TNBS downregulates OCTN2, I'd say it's causative
[PMID 17065219]. The other limiting factor might be glutamine (via the
Atb0+ transporter).
> Since
> carnitine is an antioxidant and is essential for metabolism of long
> chain fatty acids (LCFAs), lack of it could cause inflammation. On the
> other hand, during inflammation, cell many not want to metabolize
> LCFAs since they are prone to peroxidation